Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome

NCT00004466 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

NIH

Sponsor class

Stopped Very poor enrollment

Conditions

Nephrotic Syndrome
Hyperlipidemia

Interventions

DRUG: Atorvastatin
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]